References
- Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplantation: an international consensus. Clin Infect Dis 2002; 34: 7–14
- Caillot D, Couaillier JF, Bernard A, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19: 253–259
- Dasbach E J, Davies GM, Teutsch SM. Burden of aspergillosisrelated hospitalizations in the United States. Clin Infect Dis 2000; 31: 1524–1528
- Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. New Engl J Med 2002; 347: 408–415
- Latge J-P. Aspergillus fumigatus and aspergillosis. Clin Micro Rev 1999; 12: 310–350
- Lin SJ, Schranz J, Teusch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358–366
- Steinbach, WJ, Latge, J-P, Stevens, DA. Advances Against Aspergillosis. Proceedings of the Advances Against Aspergillosis Conference 9–11 September, San Francisco, USA. Med Mycol 2004; 43(Suppl. 1): S1–S319.
- Steinbach WJ, Stevens DA. Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis. Clin Infect Dis 2003; 37(Suppl. 3)S157–S187
- Steinbach, WJ, Stevens, DA, Clemons, KV, Latge, J-P, Moss, RB. 2nd Advances Against Aspergillosis. Proceeedings of the 2nd Advances Against Aspergillosis Conference 22–25 February 2006, Athens, Greece. Med Mycol; 44(Suppl. 1): S1–S392.
- Steinbach WJ, Stevens DA, Denning DW, Moss RB. Advances Against Aspergillosis. Clin Infect Dis 2003; 37(Suppl. 3)S155–S292
- H, Vanden Bossche, Mackenzie, DWR,, Cauwenbergh, G,. Aspergillus and Aspergillosis, 322 pp. New York, Plenum Press, 1988.